LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding product pipeline Ascendis Pharma has multiple rare disease product candidates in clinical development across endocrinology, oncology, and ophthalmology, offering opportunities for partnership and licensing agreements.

Strategic partnerships The company has engaged in partnerships with industry leaders like Novo Nordisk and the U.S. FDA, showcasing a collaborative approach that can lead to co-development opportunities and expanded market reach.

Financial backing With significant investments from entities like Maven Securities Ltd and a revenue range of $100M - 1B, Ascendis Pharma is well-positioned to explore growth through acquisitions, expansion, or R&D investments.

Technology utilization Utilizing innovative technologies like the TransCon platform, Ascendis Pharma demonstrates a commitment to cutting-edge solutions, making them an attractive partner for companies seeking advanced therapeutic developments.

Market presence Having a global presence with offices in various locations including the U.S. and Europe, Ascendis Pharma can leverage its international footprint to explore new markets and forge collaborations with local healthcare providers.

Similar companies to Ascendis Pharma

Ascendis Pharma Tech Stack

Ascendis Pharma uses 8 technology products and services including SAS/STAT, WordPress, SAP, and more. Explore Ascendis Pharma's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • WordPress
    Content Management System
  • SAP
    Customer Relationship Management
  • Veeva Vault
    Enterprise Content Management
  • Microsoft Dynamics 365
    Enterprise Resource Planning
  • Python
    Programming Languages
  • Vimeo
    Video Players
  • HTTP/3
    Web & Portal Technology

Media & News

Ascendis Pharma's Email Address Formats

Ascendis Pharma uses at least 2 format(s):
Ascendis Pharma Email FormatsExamplePercentage
FL@ascendispharma.comJD@ascendispharma.com
45%
FLast@ascendispharma.comJDoe@ascendispharma.com
38%
LF@ascendispharma.comDJ@ascendispharma.com
10%
FiLast@ascendispharma.comJoDoe@ascendispharma.com
7%
First.Last@ascendispharma.co.zaJohn.Doe@ascendispharma.co.za
100%

Frequently Asked Questions

Where is Ascendis Pharma's headquarters located?

Minus sign iconPlus sign iconAscendis Pharma's main headquarters is located at Tuborg Boulevard 12 Hellerup, Capital Region of Denmark 2900 DK. The company has employees across 5 continents, including EuropeNorth AmericaAfrica.

What is Ascendis Pharma's phone number?

Minus sign iconPlus sign icon You can contact Ascendis Pharma's main corporate office by phone at
+1-650-352-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ascendis Pharma's stock symbol?

Minus sign iconPlus sign iconAscendis Pharma is a publicly traded company; the company's stock symbol is ASND.

What is Ascendis Pharma's official website and social media links?

Minus sign iconPlus sign iconAscendis Pharma's official website is ascendispharma.com and has social profiles on LinkedIn.

How much revenue does Ascendis Pharma generate?

Minus sign iconPlus sign icon As of April 2025, Ascendis Pharma's annual revenue reached $750M.

What is Ascendis Pharma's SIC code NAICS code?

Minus sign iconPlus sign iconAscendis Pharma's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ascendis Pharma have currently?

Minus sign iconPlus sign iconAs of April 2025, Ascendis Pharma has approximately 1.1K employees across 5 continents, including EuropeNorth AmericaAfrica. Key team members include Chief Regulatory & Safety Officer: J. E.Chief Information Officer: L. T. P.Chief Business Officer: S. G.. Explore Ascendis Pharma's employee directory with LeadIQ.

What industry does Ascendis Pharma belong to?

Minus sign iconPlus sign iconAscendis Pharma operates in the Biotechnology Research industry.

What technology does Ascendis Pharma use?

Minus sign iconPlus sign iconAscendis Pharma's tech stack includes SAS/STATWordPressSAPVeeva VaultMicrosoft Dynamics 365PythonVimeoHTTP/3.

What is Ascendis Pharma's email format?

Minus sign iconPlus sign iconAscendis Pharma's email format typically follows the pattern of . Find more Ascendis Pharma email formats with LeadIQ.

How much funding has Ascendis Pharma raised to date?

Minus sign iconPlus sign icon As of April 2025, Ascendis Pharma has raised $300M in funding. The last funding round occurred on Sep 19, 2024 for $300M.

When was Ascendis Pharma founded?

Minus sign iconPlus sign iconAscendis Pharma was founded in 2007.
Ascendis Pharma

Ascendis Pharma

Biotechnology ResearchCapital Region of Denmark, Denmark1001-5000 Employees

Ascendis Pharma is applying our innovative TransCon technology platform to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by our core values of patients, science and passion, we utilize our TransCon technology platform to create new and potentially best-in-class therapies.

Ascendis Pharma currently has three independent endocrinology rare disease product candidates in clinical development and we're also advancing programs in Oncology and Ophthalmology. 

Ascendis Pharma is headquartered in Copenhagen, Denmark, with additional offices in Heidelberg, Munich, and Berlin, Germany, Palo Alto and Redwood City, California, and Princeton, New Jersey.

Section iconCompany Overview

Headquarters
Tuborg Boulevard 12 Hellerup, Capital Region of Denmark 2900 DK
Phone number
+1-650-352-****
Website
ascendispharma.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ASND
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $300M

    Ascendis Pharma has raised a total of $300M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $300M.

  • $100M$1B

    Ascendis Pharma's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $300M

    Ascendis Pharma has raised a total of $300M of funding over 8 rounds. Their latest funding round was raised on Sep 19, 2024 in the amount of $300M.

  • $100M$1B

    Ascendis Pharma's revenue is in the range of $100M$1B

Company Leadership

  • Stylized image of a person
    J. E.
    Chief Regulatory & Safety Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. T. P.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. G.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    I. R.
    Vice President Of Business Digitalization
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. P.
    Vice President Of Market Access
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. C.
    Chairman
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. T. P.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. M.
    Us General Counsel & Chief Compliance Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. W. J.
    Executive Vice President & Chief Legal Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. C.
    Senior Vice President And Chief Financial Officer
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.